Back |
home / stock / shmn / shmn message board
Subject | By | Source | When |
---|---|---|---|
AJH92: 1M buy at .0007 - bid increased to 18.8M at .0006 | AJH92 | investorshangout | 10/07/2020 2:39:48 PM |
AJH92: 10M buy at .0006 followed by the rest in seconds - 22M volume - .0007s up only 13M there | AJH92 | investorshangout | 10/07/2020 2:29:13 PM |
AJH92: 6M buy at .0005 - .0006s up only 19M there | AJH92 | investorshangout | 10/06/2020 4:24:44 PM |
AJH92: .0007 started - thin only 8M left | AJH92 | investorshangout | 10/02/2020 2:43:38 PM |
Greenland12: the next big 000 runner SHMN(.0006) | Greenland12 | investorshangout | 09/18/2020 7:47:29 PM |
Greenland12: SHMN~300 Generic Drugs, No R/S, Buyback, Low Float~DD 1) SHMN~ SOHM, Inc., is a growing | Greenland12 | investorshangout | 09/14/2020 12:38:17 AM |
News, Short Squeeze, Breakout and More Instantly...
Sohm Inc Company Name:
SHMN Stock Symbol:
OTCMKTS Market:
2024-06-10 13:45:34 ET CAR T-cell therapy has seen significant growth and much promise, as it provides targeted and personalized treatment for patients with certain types of cancer, particularly those that have not responded to traditional forms of treatment such as chemotherapy or radiatio...
CHINO HILLS, CA / ACCESSWIRE / June 10, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced that preliminary data from a 3 rd party user resulted in AB...
SOHM (OTC: SHMN) , a leading generic pharmaceutical and upstart biotechnology company, today announced its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. The technology holds the potential to revolutionize gen...